Cargando…
Diagnosis and management of glutaric aciduria type I – revised recommendations
Glutaric aciduria type I (synonym, glutaric acidemia type I) is a rare organic aciduria. Untreated patients characteristically develop dystonia during infancy resulting in a high morbidity and mortality. The neuropathological correlate is striatal injury which results from encephalopathic crises pre...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109243/ https://www.ncbi.nlm.nih.gov/pubmed/21431622 http://dx.doi.org/10.1007/s10545-011-9289-5 |
_version_ | 1782205405772906496 |
---|---|
author | Kölker, Stefan Christensen, Ernst Leonard, James V. Greenberg, Cheryl R. Boneh, Avihu Burlina, Alberto B. Burlina, Alessandro P. Dixon, Marjorie Duran, Marinus García Cazorla, Angels Goodman, Stephen I. Koeller, David M. Kyllerman, Mårten Mühlhausen, Chris Müller, Edith Okun, Jürgen G. Wilcken, Bridget Hoffmann, Georg F. Burgard, Peter |
author_facet | Kölker, Stefan Christensen, Ernst Leonard, James V. Greenberg, Cheryl R. Boneh, Avihu Burlina, Alberto B. Burlina, Alessandro P. Dixon, Marjorie Duran, Marinus García Cazorla, Angels Goodman, Stephen I. Koeller, David M. Kyllerman, Mårten Mühlhausen, Chris Müller, Edith Okun, Jürgen G. Wilcken, Bridget Hoffmann, Georg F. Burgard, Peter |
author_sort | Kölker, Stefan |
collection | PubMed |
description | Glutaric aciduria type I (synonym, glutaric acidemia type I) is a rare organic aciduria. Untreated patients characteristically develop dystonia during infancy resulting in a high morbidity and mortality. The neuropathological correlate is striatal injury which results from encephalopathic crises precipitated by infectious diseases, immunizations and surgery during a finite period of brain development, or develops insidiously without clinically apparent crises. Glutaric aciduria type I is caused by inherited deficiency of glutaryl-CoA dehydrogenase which is involved in the catabolic pathways of L-lysine, L-hydroxylysine and L-tryptophan. This defect gives rise to elevated glutaric acid, 3-hydroxyglutaric acid, glutaconic acid, and glutarylcarnitine which can be detected by gas chromatography/mass spectrometry (organic acids) or tandem mass spectrometry (acylcarnitines). Glutaric aciduria type I is included in the panel of diseases that are identified by expanded newborn screening in some countries. It has been shown that in the majority of neonatally diagnosed patients striatal injury can be prevented by combined metabolic treatment. Metabolic treatment that includes a low lysine diet, carnitine supplementation and intensified emergency treatment during acute episodes of intercurrent illness should be introduced and monitored by an experienced interdisciplinary team. However, initiation of treatment after the onset of symptoms is generally not effective in preventing permanent damage. Secondary dystonia is often difficult to treat, and the efficacy of available drugs cannot be predicted precisely in individual patients. The major aim of this revision is to re-evaluate the previous diagnostic and therapeutic recommendations for patients with this disease and incorporate new research findings into the guideline. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10545-011-9289-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-3109243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-31092432011-07-14 Diagnosis and management of glutaric aciduria type I – revised recommendations Kölker, Stefan Christensen, Ernst Leonard, James V. Greenberg, Cheryl R. Boneh, Avihu Burlina, Alberto B. Burlina, Alessandro P. Dixon, Marjorie Duran, Marinus García Cazorla, Angels Goodman, Stephen I. Koeller, David M. Kyllerman, Mårten Mühlhausen, Chris Müller, Edith Okun, Jürgen G. Wilcken, Bridget Hoffmann, Georg F. Burgard, Peter J Inherit Metab Dis Original Article Glutaric aciduria type I (synonym, glutaric acidemia type I) is a rare organic aciduria. Untreated patients characteristically develop dystonia during infancy resulting in a high morbidity and mortality. The neuropathological correlate is striatal injury which results from encephalopathic crises precipitated by infectious diseases, immunizations and surgery during a finite period of brain development, or develops insidiously without clinically apparent crises. Glutaric aciduria type I is caused by inherited deficiency of glutaryl-CoA dehydrogenase which is involved in the catabolic pathways of L-lysine, L-hydroxylysine and L-tryptophan. This defect gives rise to elevated glutaric acid, 3-hydroxyglutaric acid, glutaconic acid, and glutarylcarnitine which can be detected by gas chromatography/mass spectrometry (organic acids) or tandem mass spectrometry (acylcarnitines). Glutaric aciduria type I is included in the panel of diseases that are identified by expanded newborn screening in some countries. It has been shown that in the majority of neonatally diagnosed patients striatal injury can be prevented by combined metabolic treatment. Metabolic treatment that includes a low lysine diet, carnitine supplementation and intensified emergency treatment during acute episodes of intercurrent illness should be introduced and monitored by an experienced interdisciplinary team. However, initiation of treatment after the onset of symptoms is generally not effective in preventing permanent damage. Secondary dystonia is often difficult to treat, and the efficacy of available drugs cannot be predicted precisely in individual patients. The major aim of this revision is to re-evaluate the previous diagnostic and therapeutic recommendations for patients with this disease and incorporate new research findings into the guideline. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10545-011-9289-5) contains supplementary material, which is available to authorized users. Springer Netherlands 2011-03-23 2011 /pmc/articles/PMC3109243/ /pubmed/21431622 http://dx.doi.org/10.1007/s10545-011-9289-5 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Article Kölker, Stefan Christensen, Ernst Leonard, James V. Greenberg, Cheryl R. Boneh, Avihu Burlina, Alberto B. Burlina, Alessandro P. Dixon, Marjorie Duran, Marinus García Cazorla, Angels Goodman, Stephen I. Koeller, David M. Kyllerman, Mårten Mühlhausen, Chris Müller, Edith Okun, Jürgen G. Wilcken, Bridget Hoffmann, Georg F. Burgard, Peter Diagnosis and management of glutaric aciduria type I – revised recommendations |
title | Diagnosis and management of glutaric aciduria type I – revised recommendations |
title_full | Diagnosis and management of glutaric aciduria type I – revised recommendations |
title_fullStr | Diagnosis and management of glutaric aciduria type I – revised recommendations |
title_full_unstemmed | Diagnosis and management of glutaric aciduria type I – revised recommendations |
title_short | Diagnosis and management of glutaric aciduria type I – revised recommendations |
title_sort | diagnosis and management of glutaric aciduria type i – revised recommendations |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109243/ https://www.ncbi.nlm.nih.gov/pubmed/21431622 http://dx.doi.org/10.1007/s10545-011-9289-5 |
work_keys_str_mv | AT kolkerstefan diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT christensenernst diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT leonardjamesv diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT greenbergcherylr diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT bonehavihu diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT burlinaalbertob diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT burlinaalessandrop diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT dixonmarjorie diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT duranmarinus diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT garciacazorlaangels diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT goodmanstepheni diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT koellerdavidm diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT kyllermanmarten diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT muhlhausenchris diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT mulleredith diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT okunjurgeng diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT wilckenbridget diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT hoffmanngeorgf diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations AT burgardpeter diagnosisandmanagementofglutaricaciduriatypeirevisedrecommendations |